Article
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Cellular oncology : the official journal of the International Society for Cellular Oncology - 1 Jan 2009
Jonsdottir Asta Björk, Vreeswijk Maaike P G, Wolterbeek Ron, Devilee Peter, Tanke Hans J, Eyfjörd Jorunn E, Szuhai Karoly
Abstract excerpt
BACKGROUND: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability. In this study we investigated the potential role of the BRCA2 protein in cytokinesis in unmodified primary human fibroblast carrying a heterozygous mutation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
